Search for: "Mark R. Peters" Results 181 - 200 of 1,874
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Mar 2021, 1:19 pm by admin
Well, soon the pandemic of Trump Flu will come to a close. [read post]
18 Mar 2021, 12:47 am by Kluwer Patent blogger
This is about CJEU rulings in 2020 concerning appeals filed in trade mark matters – some numbers and observations – and wishes for 2021! [read post]
15 Mar 2021, 9:42 am by William Ford, Victoria Gallegos
The committee will hear testimony from Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases; David Kessler, chief science officer for COVID response at the Department of Health and Human Services; Peter Marks, director of the Center for Biologics Evaluation and Research at the Food and Drug Administration; and Rochelle Walensky, director of the Centers for Disease Control and Prevention. [read post]
8 Mar 2021, 1:20 am by Matthieu Dhenne (Ipsilon)
In practice, this procedure is also commonly used to establish “the origin, consistency and extent of the infringement” (Article R.615-2 of the Intellectual Property Code) and thus provide information on the damage suffered. [read post]
8 Mar 2021, 12:55 am by Matthieu Dhenne (Ipsilon)
In practice, this procedure is also commonly used to establish “the origin, consistency and extent of the infringement” (Article R.615-2 of the Intellectual Property Code) and thus provide information on the damage suffered. [read post]
18 Feb 2021, 5:01 am by Eugene Volokh
I'm continue to serialize my forthcoming UC Davis Law Review article What Cheap Speech Has Done: (Greater) Equality and Its Discontents; you can read the Introduction, but in this post I'm talking about how "cheap speech" has led to criminal remedies for the disclosure of private facts. [read post]
12 Feb 2021, 10:16 am by Michael Parente and Peter Fischer
” Following the arguments of Partners Mark DeLaquil and Peter Fischer and Associates Renne Knudsen and Michael Parente, who worked on the appeal, the court ruled that the NLRB’s failure to distinguish prior cases was “fatal,” stating: In addition, the Board failed to cite – let alone distinguish – a single contrary precedent even though Davidson cited several Board precedents that rejected separate units of hotel employees under similar… [read post]
2 Feb 2021, 8:04 am by Laurence Lai (Simmons & Simmons LLP)
Instead, any parts of the description which are no longer covered by the amended claims are expected to be “prominently marked” as such or deleted. [read post]
29 Jan 2021, 7:20 am by Nicolas Round (Bristows)
  If that turns out to the case then Illumina Cambridge Limited v Latvia MGI Tech SIA and others is a substantial judgment to mark this departure. [read post]
29 Jan 2021, 2:29 am by Tessa Shepperson
Peter Kyle, shadow minister for victims and youth justice said This government has failed to protect victims despite years of hard work by campaigners. [read post]
24 Jan 2021, 7:44 am
  I have been teaching the class on  "Actors, Institutions, and Legal Frameworks in International Affairs" off and on for a number of years since I helped develop the course  as part of the committee that was tasked with a role in the establishment of the School of International Affairs of Penn State University. [read post]
11 Jan 2021, 1:41 am by Matthieu Dhenne (Ipsilon)
After the year 2020, marked by the COVID-19 pandemic, 2021 also announces numerous challenges for the world, and patentees will undoubtedly have their lot. [read post]
10 Jan 2021, 10:46 am by Thorsten Bausch (Hoffmann Eitle)
Once the German trainees had overcome all of these obstacles, organized themselves and studied for months for their German Patent Attorney exams, they were just now informed by a dry notification on the GPTO’s website that In view of the ongoing COVID 19 pandemic and current developments, the German Patent and Trade Mark Office (DPMA) has decided that the patent attorney examination I/2021 will not take place on the dates previously scheduled in February 2021 (written part) and April… [read post]
More from our authors: Vissers Annotated European Patent Convention by Derk Visser, Laurence Lai, Peter de Lange, Kaisa Suominen€ 105 Handbook of Blockchain Law: A Guide to Understanding and Resolving the Legal Challenges of Blockchain Technology by Matthias Artzt, Thomas Richter€ 181 [read post]
4 Jan 2021, 1:29 pm by Matt Gluck, Tia Sewell
Meltzer, Brookings senior fellow in Global Economy and Development; Chris Meserole, director of research and policy at the Artificial Intelligence and Emerging Technology Initiative; and Mark Muro, Brookings senior fellow in the Metropolitan Policy Program. [read post]
24 Dec 2020, 9:05 pm by Max Masuda-Farkas
Peter Marks, director of FDA’s Center for Biologics Evaluation and Research, emphasized the high degree of scrutiny that the agency applied in analyzing the data on the vaccine’s results, affirming that FDA maintained “scientific standards and the integrity of our review process. [read post]